GE HealthCare Technologies Inc. (GEHC)
GEHC Stock Falls Despite New Launch to Boost Breast Cancer Diagnosis
GE HealthCare aims to deliver optimal outcomes with its innovative, patient-friendly and efficient AI-driven technology via its latest product offering.
Here's Why You Should Hold GEHC Stock in Your Portfolio for Now
GE HealthCare's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.
Goldman Sachs Gains Confidence In Market Rebound, Upgrades GE Healthcare Amid China Recovery Hopes
Last week, U.S. President Donald Trump vowed to impose a 25% tariff on imported goods from Mexico and Canada and to double tariffs on those from China to 20%.
GEHC Stock May Gain as Genesis Portfolio Expands Cloud Offerings
GE HealthCare unveils Genesis, a cloud-based imaging portfolio designed to enhance healthcare efficiency, streamline data access, and drive digital transformation.
Earnings Growth & Price Strength Make GE HealthCare Technologies (GEHC) a Stock to Watch
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
GEHC Stock May Rise on Freelium Magnet Launch, Boosts MR Access
GE HealthCare unveils Freelium, a next-gen sealed magnet platform designed to revolutionize MR imaging with minimal helium usage.
GE HealthCare Technologies (GEHC) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Is GE HealthCare Stock Trading Soaring On Thursday?
On Thursday, GE HealthCare GEHC reported fourth-quarter adjusted EPS of $1.45, up from $1.18 a year ago, beating the consensus of $1.26.
GE HealthCare Technologies Inc. (GEHC) Q4 2024 Earnings Call Transcript
GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief IR Officer Peter Arduini - President and CEO Jay Saccaro - VP and CFO Conference Call Participants Anthony Petrone - Mizuho Financial Group Craig Bijou - BofA Securities Vijay Kumar - Evercore ISI Matt Taylor - Jefferies Joanne Wuensch - Citi Larry Biegelsen - Wells Fargo David Roman - Goldman Sachs Robbie Marcus - JPMorgan Operator Good day, and thank you for standing by. Welcome to the GE HealthCare Fourth Quarter and Full Year 2024 Earnings Conference Call.
GE HealthCare Q4 Earnings Beat Estimates, Sales Miss, Net Margin Rises
GEHC's fourth-quarter results reflect strength in the Advanced Visualization Solutions and Pharmaceutical Diagnostics segments. The bottom line improves on better pricing.
GE HealthCare Tops Q4 EPS Forecasts
Medical technology and pharmaceutical diagnostics specialist GE HealthCare Technologies (GEHC -1.30%) reported mixed financial results for the fourth quarter of 2024 on Thursday, Feb. 13. Adjusted earnings per share (EPS) of $1.45 were a significant beat over the anticipated $1.27.
GE HealthCare Technologies (GEHC) Surpasses Q4 Earnings Estimates
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.18 per share a year ago.
